Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Calithera Biosciences, Inc. stock logo
CALA
Calithera Biosciences
$0.03
+19.9%
$0.02
$0.01
$0.50
$147K-0.171,583 shs393 shs
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
$31.66
$8.62
$58.94
$73.49M2.1532,471 shs77 shs
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
$0.77
+9.1%
$0.74
$0.41
$2.05
$76.29M1.03572,379 shs674,639 shs
WeedMD Inc. stock logo
WMD
WeedMD
C$0.28
-1.8%
C$0.28
C$0.23
C$0.99
C$67.82MN/A766,591 shs271,436 shs
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Calithera Biosciences, Inc. stock logo
CALA
Calithera Biosciences
0.00%-49.90%0.00%-16.50%-37.38%
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
0.00%0.00%0.00%0.00%0.00%
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
-3.55%-6.97%-0.58%+0.94%-6.97%
WeedMD Inc. stock logo
WMD
WeedMD
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Calithera Biosciences, Inc. stock logo
CALA
Calithera Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
N/AN/AN/AN/AN/AN/AN/AN/A
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
3.7066 of 5 stars
3.55.00.00.04.21.71.3
WeedMD Inc. stock logo
WMD
WeedMD
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Calithera Biosciences, Inc. stock logo
CALA
Calithera Biosciences
N/AN/AN/AN/A
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
3.00
Buy$3,400.00∞ Upside
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
3.00
Buy$5.17570.13% Upside
WeedMD Inc. stock logo
WMD
WeedMD
N/AN/AN/AN/A

Current Analyst Ratings

Latest CSU, HOOK, CALA, and WMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/25/2024
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$5.00
3/25/2024
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$6.50
1/30/2024
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$6.00 ➝ $5.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Calithera Biosciences, Inc. stock logo
CALA
Calithera Biosciences
$9.75M0.02N/AN/A($0.40) per share-0.08
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
$383.86M0.00N/AN/A($131.19) per share0.00
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
$20.13M3.79N/AN/A$0.91 per share0.85
WeedMD Inc. stock logo
WMD
WeedMD
C$27.53M2.46C$0.08 per share3.27C$0.34 per share0.81

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Calithera Biosciences, Inc. stock logo
CALA
Calithera Biosciences
-$39.65MN/A0.00N/AN/AN/AN/AN/A
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
-$295.37M$49.780.67N/AN/A40.40%N/A-5.64%N/A
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
-$81.58M-$0.88N/AN/AN/A-405.28%-72.30%-40.51%5/9/2024 (Estimated)
WeedMD Inc. stock logo
WMD
WeedMD
N/A-C$0.42N/AN/AN/AN/AN/AN/A

Latest CSU, HOOK, CALA, and WMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/22/2024Q4 2023
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
-$0.20-$0.11+$0.09N/A$3.60 million$7.41 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Calithera Biosciences, Inc. stock logo
CALA
Calithera Biosciences
N/AN/AN/AN/AN/A
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
N/AN/AN/AN/AN/A
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
N/AN/AN/AN/AN/A
WeedMD Inc. stock logo
WMD
WeedMD
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Calithera Biosciences, Inc. stock logo
CALA
Calithera Biosciences
N/AN/AN/A
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
N/A
0.11
0.11
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
N/A
3.50
3.50
WeedMD Inc. stock logo
WMD
WeedMD
95.63
3.46
1.46

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Calithera Biosciences, Inc. stock logo
CALA
Calithera Biosciences
N/A
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
62.65%
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
63.88%
WeedMD Inc. stock logo
WMD
WeedMD
N/A

Insider Ownership

CompanyInsider Ownership
Calithera Biosciences, Inc. stock logo
CALA
Calithera Biosciences
6.60%
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
5.46%
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
4.60%
WeedMD Inc. stock logo
WMD
WeedMD
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Calithera Biosciences, Inc. stock logo
CALA
Calithera Biosciences
84.87 million4.55 millionNot Optionable
Capital Senior Living Co. stock logo
CSU
Capital Senior Living
3,4162.19 million2.07 millionOptionable
Hookipa Pharma Inc stock logo
HOOK
Hookipa Pharma
5698.95 million94.40 millionOptionable
WeedMD Inc. stock logo
WMD
WeedMD
212246.62 millionN/ANot Optionable

CSU, HOOK, CALA, and WMD Headlines

SourceHeadline
Truth about WMD will finally emerge'Truth about WMD will finally emerge'
dailymail.co.uk - March 4 at 8:18 AM
No cabinet submission on costs, benefits, implications of going to war in IraqNo cabinet submission on costs, benefits, implications of going to war in Iraq
theaustralian.com.au - January 3 at 1:15 PM
Blair: Saddam still has weapons of mass destructionBlair: 'Saddam still has weapons of mass destruction'
dailymail.co.uk - October 5 at 12:01 AM
Bush administration retreats on WMD claimBush administration retreats on WMD claim
namibian.com.na - August 29 at 6:28 AM
Missing WMD ‘hurting war on terror’Missing WMD ‘hurting war on terror’
namibian.com.na - August 29 at 6:28 AM
Weapons of Mass Destruction and the ethics of their usageWeapons of Mass Destruction and the ethics of their usage
arstechnica.com - August 17 at 11:16 PM
Russia used sabotaged dam as ‘weapon of mass destruction’ says UkraineRussia used sabotaged dam as ‘weapon of mass destruction’ says Ukraine
politico.eu - June 12 at 4:56 PM
US, South Korea issue fresh North Korea sanctions on illicit IT workforceUS, South Korea issue fresh North Korea sanctions on 'illicit' IT workforce
asahi.com - May 27 at 11:26 PM
Malaysia Gets Tough on WMDMalaysia Gets Tough on WMD
thediplomat.com - May 27 at 11:26 PM
Interpol Tackles WMD TerrorismInterpol Tackles WMD Terrorism
thediplomat.com - May 21 at 5:30 PM
Weapons of mass destruction found'Weapons of mass destruction found'
dailymail.co.uk - May 20 at 3:39 PM
Chemical Weapons are NOT WMDsChemical Weapons are NOT WMDs
thediplomat.com - May 17 at 6:51 PM
The Next Financial WMD?The Next Financial WMD?
thestreet.com - May 14 at 11:37 PM
The Week in Weed – May 6, 2023 - StratCannThe Week in Weed – May 6, 2023 - StratCann
news.google.com - May 6 at 3:33 PM
WMD in Iraq: Evidence and ImplicationsWMD in Iraq: Evidence and Implications
medscape.com - April 28 at 10:49 AM
What happened when WMD experts tried to make the GPT-4 AI do bad thingsWhat happened when WMD experts tried to make the GPT-4 AI do bad things
thebulletin.org - April 2 at 12:38 AM
Mass DestructionMass Destruction
bostonreview.net - March 31 at 1:34 PM
Bush’s Iraq War Lies Created a Blueprint for Donald TrumpBush’s Iraq War Lies Created a Blueprint for Donald Trump
theintercept.com - March 22 at 8:37 AM
Column: The road to war: An ex-Reuters journalist recalls the chase for WMD in IraqColumn: The road to war: An ex-Reuters journalist recalls the chase for WMD in Iraq
reuters.com - March 22 at 8:37 AM
So where were they, Mr Blair? How The Independent exposed the lie of Saddam’s WMD and the justification for an illegal warSo where were they, Mr Blair? How The Independent exposed the lie of Saddam’s WMD and the justification for an illegal war
independent.co.uk - March 22 at 8:37 AM
WMD Inspector: Bush should have faced war crimes court over Iraq invasionWMD Inspector: Bush should have faced war crimes court over Iraq invasion
msnbc.com - March 22 at 8:37 AM
The Biden administration overestimates radiological terrorism risks and underplays biothreatsThe Biden administration overestimates radiological terrorism risks and underplays biothreats
thebulletin.org - March 20 at 12:32 AM
Middle East ProgramMiddle East Program
csis.org - February 11 at 7:33 AM
Former WeedMD employee, ex-mutual fund dealer fined for stock scheme - The London Free PressFormer WeedMD employee, ex-mutual fund dealer fined for stock scheme - The London Free Press
news.google.com - January 15 at 8:21 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Calithera Biosciences logo

Calithera Biosciences

NASDAQ:CALA
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
Capital Senior Living logo

Capital Senior Living

NYSE:CSU
Capital Senior Living Corp. engages in the operation of senior housing communities. Its senior living options include independent living, assisted living, and memory care. The company was founded in 1990 and is headquartered in Dallas, TX.
Hookipa Pharma logo

Hookipa Pharma

NASDAQ:HOOK
HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.
WeedMD logo

WeedMD

CVE:WMD
WeedMD Inc. produces, distributes, and sells medical-grade cannabis in Canada. It offers dried cannabis, cannabis plants and seeds, cannabis oil, edibles, extracts and topicals, and others, as well as cannabis flower products. The company sells its products directly to medical patients and strategic relationships across the seniors' market, as well as through supply agreements with Shoppers Drug Mart and six provincial distribution agencies under the Color Cannabis, Saturday, Starseed, and WeedMD brand names. WeedMD Inc. is headquartered in Aylmer, Canada.